KHDRBS3 promotes multi‐drug resistance and anchorage‐independent growth in colorectal cancer

5‐Fluorouracil (5‐FU) is one of the most frequently used pharmacological agents in the treatment of colorectal cancer (CRC). Resistance to chemotherapy is a major cause of treatment failure of CRC, and it is a well known fact that cancer stem cells play a significant role in the acquisition of drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Ukai, Shoichi, Sakamoto, Naoya, Taniyama, Daiki, Harada, Kenji, Honma, Ririno, Maruyama, Ryota, Naka, Kazuhito, Hinoi, Takao, Takakura, Yuji, Shimizu, Wataru, Ohdan, Hideki, Yasui, Wataru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935809/
https://www.ncbi.nlm.nih.gov/pubmed/33423358
http://dx.doi.org/10.1111/cas.14805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935809/
https://www.ncbi.nlm.nih.gov/pubmed/33423358
http://dx.doi.org/10.1111/cas.14805

Ejemplares similares